Navigation Links
Supratek Pharma Inc. announced today that under the Special Protocol
Date:11/28/2007

Assessment (SPA) process, it has obtained agreement with the United States Food and Drug Administration (FDA) for the design of its pivotal study protocol for SP1049C for the treatment of metastatic adenocarcinoma of the

upper gastrointestinal tract

MONTREAL, Nov. 28 /PRNewswire/ - The randomized, multicenter Phase III pivotal clinical trial will compare SP1049C plus Best Supportive Care (BSC) versus BSC alone for the treatment of patients with advanced adenocarcinoma of the esophagus, gastroesophageal junction and stomach who have failed adjuvant or 1st or 2nd line chemotherapy. Supratek Pharma is the sponsor of the international trial and its Clinical Oncology team will direct the clinical development program.

Oleg Romar, President and Chief Executive Officer, said, "We are pleased that the FDA has accepted our Phase III clinical protocol for SP1049C. This acceptance is a significant milestone and represents a critical step in the advancement of our clinical program. We believe that SP1049C, a novel anthracycline, may be a breakthrough treatment for this patient population. FDA's agreement in writing to a protocol reviewed under this process is considered binding on the review division of the FDA, providing that the protocol is followed and no substantial scientific issues arise regarding the safety or efficacy of the drug after the testing has begun."

"In the SPA communication, the FDA advised that the clinical design and analysis plan of our submitted protocol are suitable to provide evidence of safety and efficacy to support a new drug application (NDA) for SP1049C for the treatment of cancer of the upper gastrointestinal tract," said Dr. Christopher E. Newman, Vice President and Chief Medical Officer of Supratek Pharma. "The protocol for this trial was optimized with contributions from world opinion leaders in oncology. We look forward to the launching of this important pivotal study."

About SP1049C
'/>"/>

SOURCE Supratek Pharma Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Supratek Pharma Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for SP1049C for the treatment of metastatic adenocarcinoma of the upper gastrointestinal tract
2. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
3. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
9. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
10. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
11. Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... 2015 , ... Mullin/Ashley Associates, Inc. , an integrated ... the Service Industry Advertising Awards 12th annual national competition. , The awards ... University of Maryland Shore Regional Health. , A Gold Award was won by ...
(Date:7/30/2015)... ... 2015 , ... Google recently announced that it will be disclosing any incidents ... a June 8, 2015 article published by Nasdaq , the powerful tech company ... its computer-driven cars, which such industry players as Tesla CEO Elon Musk believe may ...
(Date:7/30/2015)... ... July 30, 2015 , ... " ... which takes a look at small, medium, and large businesses making an impact ... conducted the business review and shared with viewers how DevExpress has provided software ...
(Date:7/30/2015)... ... 2015 , ... 24/7 Care At Home, a high-quality provider of comprehensive home ... the Centers for Medicare and Medicaid (CMS) have awarded its agency the highest star ... At Home’s agency is one of three top Orange County agencies to earn the ...
(Date:7/30/2015)... ... July 30, 2015 , ... The need for accessibility is never greater ... comfort to patients as well as visiting friends and family during these critical moments, ... , The stations - powered by ChargeItSpot , a Philadelphia-based startup that recently ...
Breaking Medicine News(10 mins):Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 2Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 3Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 2Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 3Health News:Software to Develop High-Performance Data-Driven Apps was Featured on NewsWatch Television 2Health News:24/7 Care At Home Earns a 5-Star Rating from the Centers for Medicare and Medicaid (CMS) 2Health News:Hospitals Add Phone Charging Stations as an Amenity for Patients and Visitors 2
... A toxic pollutant spread by oil spills, forest fires ... and may represent a second way in which smoking ... the annual meeting of the Orthopaedic Research Society in ... University of Rochester Medical Center identified one ingredient in ...
... Whitemark Homes, Inc.,(OTC Bulletin Board: WTMK), ... letter of,intent to acquire Metiscan Holdings, Inc. ... owned subsidiary Metiscan Technologies, Inc.,headquartered in Dallas, ... products and services that streamline the management ...
... SpectraScience, Inc. (OTC,Bulletin Board: SCIE), a San Diego ... placed its LUMA Cervical Imaging System to detect,pre-cancers ... the,direction of Dr. Stephen Poliakoff., The LUMA ... detection of high-grade precancerous cervical abnormalities that have,the ...
... Vapotherm, the,global leader in High Flow Oxygen ... Robert Storey earned Maryland,s 2008 International,Business Leadership Award ... one of seven winners selected by the WTCI ... international,business. The award will be presented to Storey ...
... a result of mutations in a given cell that ... the University of Helsinki, Finland, has demonstrated that in ... development are mutations in the smooth muscle cells, previously ... of interactions between tissue types, and open up possibilities ...
... partner, DNA Research, officially launches Suracell ... expected to open soon, SOUTH ORANGE, N.J., ... leading provider of genetically directed,personalized age management programs, ... of worldwide partnerships to bring its cutting edge ...
Cached Medicine News:Health News:Toxins in cigarette smoke prevent stem cells from becoming cartilage 2Health News:Toxins in cigarette smoke prevent stem cells from becoming cartilage 3Health News:Whitemark Homes Signs Letter of Intent to Acquire Metiscan Holdings, Inc. 2Health News:South Florida Gynecologic Oncologists Begin Using LUMA(R) Cervical Pre-Cancer Imaging Device 2Health News:South Florida Gynecologic Oncologists Begin Using LUMA(R) Cervical Pre-Cancer Imaging Device 3Health News:Anti-Aging/Genetic Health Leader Suracell, Inc. Expands Internationally 2
(Date:7/30/2015)... 30, 2015  Cleveland Clinic President Wael Barsoum ... last month that industry is compelled to adopt declining ... the efficiencies—and develop the transformational innovations -- required to ... were preceded by Doug Kohrs , past President ... who stressed that industry must add "episode of care," ...
(Date:7/30/2015)... July 30, 2015 ... report with market overview, trends, DRO analysis, ... analysis, recent developments, competitive scenario and top ... Insight: Biosensors Market Development and Demand Forecast ... http://photos.prnewswire.com/prnh/20150727/756778 ) Explore more about ...
(Date:7/30/2015)... July 30, 2015 Vermillion, Inc. ... gynecologic disease, announced today it will report ... the market close on Thursday, August 13, ... and webcast at 4:30pm Eastern.Conference Call and ... 4:30pm Eastern/1:30pm Pacific  Domestic: , ...
Breaking Medicine Technology:Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5
... $5 Million Payment from Roche- , , ... (Nasdaq: MEMY ) today announced that it has ... R3487/MEM 3454, its lead alpha-7 nicotinic receptor agonist, in cognitive ... 212 patients in the Phase 2 trial, triggering a $5.0 ...
... MALVERN, Pa., Nov. 18 Arlington Medical Resources (AMR), ... diagnostic,imaging industries, finds that over $10 million of CSL ... quarter of 2008. Privigen is the newest,brand of intravenous ... of 2008. IVIG is a product created from the ...
Cached Medicine Technology:Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2
Inquire...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With polished ...
... with concave seats and standard-sized backrests ... like seats, backrests, armrests, and casters ... recommended for the following environments: industry, ... health care and office. • With ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With reinforced ...
Medicine Products: